Literature DB >> 20578200

Low CD49d expression and long telomere identify a chronic lymphocytic leukemia subset with highly favourable outcome.

Davide Rossi, Chiara Lobetti Bodoni, Antonella Zucchetto, Silvia Rasi, Lorenzo De Paoli, Marco Fangazio, Francesca Maria Rossi, Marco Ladetto, Valter Gattei, Gianluca Gaidano.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20578200     DOI: 10.1002/ajh.21756

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  5 in total

Review 1.  Association between telomere length and survival in cancer patients: a meta-analysis and review of literature.

Authors:  Xinsen Xu; Kai Qu; Qing Pang; Zhixin Wang; Yanyan Zhou; Chang Liu
Journal:  Front Med       Date:  2016-05-16       Impact factor: 4.592

Review 2.  The Role of CD44 in the Pathophysiology of Chronic Lymphocytic Leukemia.

Authors:  Julia Christine Gutjahr; Richard Greil; Tanja Nicole Hartmann
Journal:  Front Immunol       Date:  2015-04-20       Impact factor: 7.561

Review 3.  Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy.

Authors:  Sara Martinelli; Antonio Cuneo; Luca Formigaro; Maurizio Cavallari; Enrico Lista; Francesca Maria Quaglia; Maria Ciccone; Antonella Bardi; Eleonora Volta; Elisa Tammiso; Elena Saccenti; Olga Sofritti; Giulia Daghia; Massimo Negrini; Melissa Dabusti; Paolo Tomasi; Sabrina Moretti; Francesco Cavazzini; Gian Matteo Rigolin
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-10-15       Impact factor: 2.576

Review 4.  Integrin Signaling Shaping BTK-Inhibitor Resistance.

Authors:  Laura Polcik; Svenja Dannewitz Prosseda; Federico Pozzo; Antonella Zucchetto; Valter Gattei; Tanja Nicole Hartmann
Journal:  Cells       Date:  2022-07-18       Impact factor: 7.666

Review 5.  The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia.

Authors:  Gabriele Brachtl; Josefina Piñón Hofbauer; Richard Greil; Tanja Nicole Hartmann
Journal:  Ann Hematol       Date:  2013-11-28       Impact factor: 3.673

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.